Crossmark

Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient’s Compliance

Crossref DOI link: https://doi.org/10.1208/s12249-024-02796-9

Published Online: 2024-04-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Juan, Candela https://orcid.org/0000-0003-0299-9041
Gallo, Loreana https://orcid.org/0000-0001-8745-9620
Gonzalez Vidal, Noelia https://orcid.org/0000-0002-0687-0096
License Information

Text and Data Mining valid from 2024-04-08

Version of Record valid from 2024-04-08
More Information

Article History

Received: 4 December 2023

Accepted: 25 March 2024

First Online: 8 April 2024

Declarations

:

: The authors declare no competing interests.